Free Trial

iShares Genomics Immunology and Healthcare ETF (IDNA) Institutional Ownership

iShares Genomics Immunology and Healthcare ETF logo
$29.52 -0.13 (-0.44%)
As of 04:10 PM Eastern

Institutional Ownership Changes (13F Filings) for iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$3.25M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$432.89K
Get IDNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling iShares Genomics Immunology and Healthcare ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IDNA Institutional Buying and Selling by Quarter

iShares Genomics Immunology and Healthcare ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/23/2025Triumph Capital Management1,481$35K0.0%N/A0.029%
11/17/2025Triumph Capital Management1,481$35K0.0%N/A0.029%
11/17/2025Flow Traders U.S. LLC27,716$655K0.0%-39.0%0.549%
11/17/2025Ameriprise Financial Inc.71,473$1.69M0.0%+8.4%1.415%
11/10/2025Portland Global Advisors LLC103,007$2.43M0.3%+0.7%2.040%
8/15/2025Ameriprise Financial Inc.65,933$1.35M0.0%-1.1%1.280%
8/13/2025Flow Traders U.S. LLC45,404$931K0.0%N/A0.882%
8/13/2025Portland Global Advisors LLC102,323$2.10M0.2%N/A1.987%
4/22/2025Cambridge Investment Research Advisors Inc.19,797$406K0.0%+4.0%0.374%
2/17/2025Ameriprise Financial Inc.71,832$1.63M0.0%+23.6%1.228%
1/17/2025Avior Wealth Management LLC26,650$603K0.0%+180.5%0.456%
11/8/2024Avior Wealth Management LLC9,500$234K0.0%N/A0.162%
2/5/2024RiverFront Investment Group LLC38,919$896K0.0%-5.2%0.643%
11/15/2023Integrated Wealth Concepts LLC56,879$1.16M0.0%-14.7%0.940%
11/7/2023RiverFront Investment Group LLC41,046$835K0.0%-3.3%0.678%
8/1/2023RiverFront Investment Group LLC42,454$991K0.0%-2.7%0.696%
7/13/2023Cambridge Investment Research Advisors Inc.32,104$750K0.0%+6.5%0.526%
5/3/2023Integrated Wealth Concepts LLC10,876$253K0.0%N/A0.175%
4/28/2023Janney Montgomery Scott LLC39,360$916K0.0%-3.4%0.635%
3/6/2023OLD Mission Capital LLC5,298$133K0.0%N/A0.086%
2/24/2023RiverFront Investment Group LLC45,602$1.15M0.3%+96.0%0.741%
2/13/2023Wealthcare Advisory Partners LLC217,907$5.49M0.3%+23.9%3.543%
2/8/2023Cambridge Investment Research Advisors Inc.29,579$745K0.0%+2.2%0.481%
2/1/2023Janney Montgomery Scott LLC40,741$1.03M0.0%N/A0.662%
1/31/2023Westside Investment Management Inc.350$2.51M0.0%-66.7%0.006%
1/26/2023Vigilant Capital Management LLC1,000$25K0.0%N/A0.016%
1/25/2023Mayflower Financial Advisors LLC21,752$547K0.1%-6.9%0.354%
11/15/2022Flow Traders U.S. LLC11,470$303K0.0%N/A0.178%
11/9/2022Westside Investment Management Inc.1,050$21.21M0.1%+200.0%0.016%
10/17/2022Cambridge Investment Research Advisors Inc.28,952$764K0.0%-11.5%0.449%
8/8/2022Baird Financial Group Inc.33,338$963K0.0%-19.4%0.529%
8/2/2022Triumph Capital Management18,382$160K0.1%N/A0.292%
7/13/2022Cambridge Investment Research Advisors Inc.32,731$946K0.0%+55.4%0.515%
5/5/2022RiverFront Investment Group LLC24,394$840K0.0%+90.0%0.372%
4/21/2022Mayflower Financial Advisors LLC29,021$1M0.1%+32.6%0.427%
4/15/2022Wealthcare Advisory Partners LLC165,681$5.71M0.3%+26.6%2.436%
4/12/2022Wealthcare Capital Management LLC5,881$203K0.0%N/A0.086%
2/10/2022RiverFront Investment Group LLC12,842$563K0.0%N/A0.183%
2/9/2022Baird Financial Group Inc.50,228$2.20M0.0%+2.8%0.718%


IDNA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IDNA shares?

During the previous two years, the following institutional investors and hedge funds held shares of iShares Genomics Immunology and Healthcare ETF shares: Portland Global Advisors LLC ($2.43M), Ameriprise Financial Inc. ($1.69M), Flow Traders U.S. LLC ($655K), Avior Wealth Management LLC ($603K), and Cambridge Investment Research Advisors Inc. ($406K), Triumph Capital Management ($35K).Learn more on iShares Genomics Immunology and Healthcare ETF's institutional investors.

Which institutional investors have been buying iShares Genomics Immunology and Healthcare ETF's stock?

The following institutional investors have purchased iShares Genomics Immunology and Healthcare ETF's stock in the last 24 months: Portland Global Advisors LLC ($103.01K), Flow Traders U.S. LLC ($45.40K), Avior Wealth Management LLC ($26.65K), Ameriprise Financial Inc. ($19.26K), Triumph Capital Management ($2.96K), and Cambridge Investment Research Advisors Inc. ($756.00).

How much institutional buying is happening at iShares Genomics Immunology and Healthcare ETF?

Institutional investors have bought a total of 156,913 shares in the last 24 months. This purchase volume represents approximately $3.25M in transactions.

Which of iShares Genomics Immunology and Healthcare ETF's major shareholders have been selling company stock?

The following institutional investors have sold iShares Genomics Immunology and Healthcare ETF stock in the last 24 months: Flow Traders U.S. LLC ($17.69K), and Ameriprise Financial Inc. ($745.00).

How much institutional selling is happening at iShares Genomics Immunology and Healthcare ETF?

Institutional investors have sold a total of 18,433 shares in the last 24 months. This volume of shares sold represents approximately $432.89K in transactions.



This page (NYSEARCA:IDNA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners